Related Experiment Video

Updated: May 25, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

[Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)]

Naoki Suzuki1, Maki Tateyama, Hitoshi Warita

  • 1Department of Neurology, Tohoku University School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|January 27, 2012
PubMed

Insights

Sporadic inclusion body myositis (sIBM) is a progressive muscle disease with unknown causes and no effective treatments. This review examines sIBM prevalence in Japan and discusses its underlying mechanisms to guide future therapies.

Area of Science:

  • Neurology
  • Genetics
  • Aging Research

Context:

  • Sporadic inclusion body myositis (sIBM) is a debilitating and progressive skeletal muscle disease.
  • The exact etiology of sIBM remains unknown, with potential contributing factors including genetics, aging, lifestyle, and environmental influences.
  • Current treatments like steroids and immunosuppressants are generally ineffective for sIBM.

Purpose:

  • To estimate the prevalence of sporadic inclusion body myositis (sIBM) in Japan.
  • To discuss the potential pathomechanisms underlying sIBM.
  • To provide insights for developing effective therapeutic approaches for sIBM.

Summary:

  • This review estimates the prevalence of sporadic inclusion body myositis (sIBM) in Japan.
  • It explores the complex and unknown etiology of sIBM, considering genetic, aging, lifestyle, and environmental factors.
  • The discussion focuses on elucidating the pathomechanisms of sIBM, crucial for advancing treatment strategies.

Impact:

  • Understanding sIBM prevalence in Japan can inform public health strategies and resource allocation.
  • Elucidating sIBM pathomechanisms is essential for developing targeted and effective therapies.
  • This review contributes to the scientific knowledge base, potentially accelerating the development of treatments for this intractable disease.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...